⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 15/03/22 | 07:00:02 | 15 Mar 2022 | Lipid inCode pilot | |
| 21/02/22 | 13:17:20 | 21 Feb 2022 | Confirmation of board appointment | |
| 08/02/22 | 07:00:03 | 8 Feb 2022 | Positive results for Lipid inCode in NHS study | |
| 21/01/22 | 07:00:16 | 21 Jan 2022 | Proposed independent directorate appointment | |
| 10/01/22 | 07:00:08 | 10 Jan 2022 | FDA Pre-Submission for Cardio inCode-SCORE | |
| 29/11/21 | 07:00:09 | 29 Nov 2021 | Directorate Change | |
| 25/11/21 | 07:00:03 | 25 Nov 2021 | Trading update | |
| 17/09/21 | 10:38:08 | 17 Sept 2021 | Grant of Share Options and PDMR dealing | |
| 16/09/21 | 07:00:02 | 16 Sept 2021 | Half-year Report | |
| 10/09/21 | 07:00:05 | 10 Sept 2021 | Holding(s) in Company | |
| 02/09/21 | 07:00:08 | 2 Sept 2021 | Notice of Results |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 15/03/22 | 07:00:02 | 15 Mar 2022 | Lipid inCode pilot | |
| 21/02/22 | 13:17:20 | 21 Feb 2022 | Confirmation of board appointment | |
| 08/02/22 | 07:00:03 | 8 Feb 2022 | Positive results for Lipid inCode in NHS study | |
| 21/01/22 | 07:00:16 | 21 Jan 2022 | Proposed independent directorate appointment | |
| 10/01/22 | 07:00:08 | 10 Jan 2022 | FDA Pre-Submission for Cardio inCode-SCORE | |
| 29/11/21 | 07:00:09 | 29 Nov 2021 | Directorate Change | |
| 25/11/21 | 07:00:03 | 25 Nov 2021 | Trading update | |
| 17/09/21 | 10:38:08 | 17 Sept 2021 | Grant of Share Options and PDMR dealing | |
| 16/09/21 | 07:00:02 | 16 Sept 2021 | Half-year Report | |
| 10/09/21 | 07:00:05 | 10 Sept 2021 | Holding(s) in Company | |
| 02/09/21 | 07:00:08 | 2 Sept 2021 | Notice of Results |
